Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;190(4):610-617.
doi: 10.1111/bjh.16651. Epub 2020 Apr 20.

Deficit of circulating CD19+ CD24hi CD38hi regulatory B cells in severe aplastic anaemia

Affiliations

Deficit of circulating CD19+ CD24hi CD38hi regulatory B cells in severe aplastic anaemia

Yoshitaka Zaimoku et al. Br J Haematol. 2020 Aug.

Abstract

Immune aplastic anaemia (AA) is caused by cytotoxic T lymphocytes (CTLs) that destroy haematopoietic stem and progenitor cells. Enhanced type 1 T helper (Th1) responses and reduced regulatory T cells (Tregs) are involved in the immune pathophysiology. CD24hi CD38hi regulatory B cells (Bregs) suppress CTLs and Th1 responses, and induce Tregs via interleukin 10 (IL-10). We investigated circulating B-cell subpopulations, including CD24hi CD38hi Bregs, as well as total B cells, CD4+ T cells, CD8+ T cells and natural killer cells in 104 untreated patients with severe and very severe AA, aged ≥18 years. All patients were treated with standard immunosuppressive therapy (IST) plus eltrombopag. CD24hi CD38hi Bregs were markedly reduced in patients with AA compared to healthy individuals, especially in very severe AA, but residual Bregs remained functional, capable of producing IL-10; total B-cell counts and the other B-cell subpopulations were similar to those of healthy individuals. CD24hi CD38hi Bregs did not correlate with responses to IST, and they recovered to levels present in healthy individuals after therapy. Mature naïve B-cell counts were unexpectedly associated with IST response. Markedly reduced CD24hi CD38hi Bregs, especially in very severe AA, with recovery after IST suggest Breg deficits may contribute to the pathophysiology of immune AA.

Keywords: aplastic anaemia; flow cytometry; immunosuppressive therapy; lymphocyte subsets; regulatory B cells.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

Fig 1
Fig 1
B‐cell subpopulations. (A) Representative dot plots in a healthy individual and a patient with AA. CD3CD19+CD33GPI‐anchor+ live B cells were classified based on their expressions of CD24 and CD38: CD24hiCD38hi Bregs, CD24lowCD38low mature naïve B cells, CD24hiCD38low memory B cells, and CD24lowCD38hi plasma cells/plasmablasts. (B) Comparisons of CD24hiCD38hi Breg frequencies among healthy individuals (n = 29), patients with SAA (n = 37) and VSAA (n = 23). [Colour figure can be viewed at wileyonlinelibrary.com]
Fig 2
Fig 2
B‐cell subpopulation frequencies and response to IST. (A) Initial CD24hiCD38hi Bregs did not correlate with IST responses. (B) Among eight lymphocyte subsets studied, only mature naïve B cells correlated with haematological responses. (C) CD24hiCD38hi Bregs recovered in 6 months after institution of ATG in both responders (blue dot lines, n = 34) and non‐responders (red solid lines, n = 5). R, responders; NR, non‐responders. [Colour figure can be viewed at wileyonlinelibrary.com]
Fig 3
Fig 3
IL‐10 production from B cells. (A) Representative dot plots of intracellular IL‐10 staining in CD24hiCD38hi Bregs and non‐Breg B cells. The control was B cells cultured without brefeldin A. (B) IL‐10+ B‐cell frequencies in total B cells were reduced in patients with AA (n = 33) compared to healthy individuals (n = 12). (C) IL‐10+ cell frequencies in B‐cell subpopulations in healthy individuals (n = 12) and patients with AA (n = 10). Intracellular IL‐10+ B cells were significantly enriched in CD24hiCD38hi Bregs in both groups. [Colour figure can be viewed at wileyonlinelibrary.com]

Comment in

References

    1. Young NS. Aplastic anemia. N Engl J Med. 2018;379:1643–56. - PMC - PubMed
    1. Babushok DV, Duke JL, Xie HM, Stanley N, Atienza J, Perdigones N, et al. Somatic HLA mutations expose the role of class I‐mediated autoimmunity in aplastic anemia and its clonal complications. Blood Adv. 2017;1:1900–10. - PMC - PubMed
    1. Katagiri T, Sato‐Otsubo A, Kashiwase K, Morishima S, Sato Y, Mori Y, et al. Frequent loss of HLA alleles associated with copy number‐neutral 6pLOH in acquired aplastic anemia. Blood. 2011;118:6601–9. - PubMed
    1. Yoshizato T, Dumitriu B, Hosokawa K, Makishima H, Yoshida K, Townsley D, et al. Somatic mutations and clonal hematopoiesis in aplastic anemia. N Engl J Med. 2015;373:35–47. - PMC - PubMed
    1. Zaimoku Y, Takamatsu H, Hosomichi K, Ozawa T, Nakagawa N, Imi T, et al. Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia. Blood. 2017;129:2908–16. - PubMed

Publication types

MeSH terms